It acts as a dual agonist of the glucose-dependent insulinotropic polypeptide (GIP) and glucagon-like peptide-1 (GLP-1) receptors in experimental settings
doi: 10.3389/fendo.2025.1586589 Received 03 March 2025 Accepted 29 April 2025 Published 21 May 2025 Volume 16 - 2025 Edited by Giacomina Brunetti, University of Bari Aldo Moro, Italy Reviewed by Nagesha Guthalu Kondegowda, City of Hope, United States Nikita Nirwan, Jamia Hamdard University, India Updates Copyright 2025 Chen, Lyu, Zhao, Han, Huang, Yang and Zhou
Biol Proced Online
11 There was only one case, but this was out of a group of only 80 subjects
However, the Delphi process also identified several areas of uncertainty, which require further research